Skip to main content
OpenTrials

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

840 public trials 219 recruiting studies
Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Active, Not Recruiting

SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus

NCT06144710

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
  • First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Shenzhen People's Hospital Shenzhen, Guangdong, China
View Trial Details
Active, Not Recruiting

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

NCT05138133

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Research Site Glendale, Arizona, United States
  • Research Site La Palma, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Upland, California, United States
View all 167 locations
View Trial Details
Active, Not Recruiting

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

NCT04895241

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations
  • Tilda Research Birmingham Homewood, Alabama, United States
  • Wallace Rheumatic Study Center Beverly Hills, California, United States
  • University of Southern California Los Angeles, California, United States
  • Providence Facey Medical Foundation Mission Hills, California, United States
View all 164 locations
View Trial Details
Active, Not Recruiting

Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases

NCT04276701

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • CHU de Bordeaux - service de médecine interne Bordeaux, France
  • CHU de Brest - service de rhumatologie Brest, France
  • CHRU de Lille - service de Médecine Interne Lille, France
  • AP-HP - Hôpital Cochin - service de Médecine Interne Paris, France
View Trial Details
Active, Not Recruiting

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

NCT04961567

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Arthritis & Rheumatology Associates, P.C. Glendale, Arizona, United States
  • Care Access Research - Huntington BeachCare Access Research - Huntington Beach Huntington Beach, California, United States
  • Valerius Medical Group Los Alamitos, California, United States
View all 177 locations
View Trial Details
Active, Not Recruiting

A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

NCT06255028

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Dermatomyositis, +27 more
Locations
  • Keck School of Medicine of University of Southern California Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Lurie Children's; Northwestern Medicine - Northwestern Medical Group Chicago, Illinois, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details

Related conditions